Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Comparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 Diabetes

ClinicalTrials.gov ID: NCT00097877

Public ClinicalTrials.gov record NCT00097877. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 18, 2026, 1:16 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Comparison of the Effect on Glycemic Control of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Combination With Metformin in Subjects With Type 2 Diabetes

Study identification

NCT ID
NCT00097877
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novo Nordisk A/S
Industry
Enrollment
293 participants

Conditions and interventions

Interventions

  • biphasic insulin aspart Drug
  • insulin glargine Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 31, 2004
Primary completion
Oct 31, 2006
Completion
Oct 31, 2006
Last update posted
Jan 10, 2017

2005 – 2006

United States locations

U.S. sites
71
U.S. states
31
U.S. cities
62
Facility City State ZIP Site status
Novo Nordisk Investigational Site Birmingham Alabama 35235
Novo Nordisk Investigational Site Tuscaloosa Alabama 35406
Novo Nordisk Investigational Site Vestavia Hills Alabama 35209
Novo Nordisk Investigational Site Searcy Arkansas 72143
Novo Nordisk Investigational Site Chula Vista California 91911
Novo Nordisk Investigational Site Fullerton California 92835
Novo Nordisk Investigational Site Orange California 92868
Novo Nordisk Investigational Site Orange California 92869
Novo Nordisk Investigational Site New Britain Connecticut 06050
Novo Nordisk Investigational Site Aventura Florida 33180
Novo Nordisk Investigational Site Chiefland Florida 32626
Novo Nordisk Investigational Site Fort Myers Florida 33907
Novo Nordisk Investigational Site Jacksonville Florida 32208
Novo Nordisk Investigational Site Melbourne Florida 32901
Novo Nordisk Investigational Site Ocala Florida 34471
Novo Nordisk Investigational Site Plantation Florida 33324
Novo Nordisk Investigational Site Atlanta Georgia 30303
Novo Nordisk Investigational Site Atlanta Georgia 30339
Novo Nordisk Investigational Site Boise Idaho 83702
Novo Nordisk Investigational Site Chicago Illinois 60607
Novo Nordisk Investigational Site New Albany Indiana 47150
Novo Nordisk Investigational Site Des Moines Iowa 50314
Novo Nordisk Investigational Site Overland Park Kansas 66209
Novo Nordisk Investigational Site Topeka Kansas 66606
Novo Nordisk Investigational Site Baton Rouge Louisiana 70808
Novo Nordisk Investigational Site Baltimore Maryland 21204
Novo Nordisk Investigational Site Springfield Massachusetts 01107
Novo Nordisk Investigational Site Chesterfield Missouri 63017
Novo Nordisk Investigational Site St Louis Missouri 63017
Novo Nordisk Investigational Site St Louis Missouri 63141
Novo Nordisk Investigational Site Omaha Nebraska 68114
Novo Nordisk Investigational Site Las Vegas Nevada 89119-6100
Novo Nordisk Investigational Site Cherry Hill New Jersey 08034
Novo Nordisk Investigational Site Lawrenceville New Jersey 08648
Novo Nordisk Investigational Site Plainsboro New Jersey 08536
Novo Nordisk Investigational Site New Hyde Park New York 11042
Novo Nordisk Investigational Site Staten Island New York 10305
Novo Nordisk Investigational Site Syracuse New York 13210
Novo Nordisk Investigational Site Greensboro North Carolina 27408
Novo Nordisk Investigational Site Dayton Ohio 45406
Novo Nordisk Investigational Site Dayton Ohio 45439
Novo Nordisk Investigational Site Kettering Ohio 45429
Novo Nordisk Investigational Site Clinton Oklahoma 73601
Novo Nordisk Investigational Site Tulsa Oklahoma 74104
Novo Nordisk Investigational Site Eugene Oregon 97401
Novo Nordisk Investigational Site Portland Oregon 97239
Novo Nordisk Investigational Site Salem Oregon 97302
Novo Nordisk Investigational Site Lancaster Pennsylvania 17601
Novo Nordisk Investigational Site Melrose Park Pennsylvania 19027
Novo Nordisk Investigational Site Norristown Pennsylvania 19401
Novo Nordisk Investigational Site West Reading Pennsylvania 19611
Novo Nordisk Investigational Site Greer South Carolina 29651
Novo Nordisk Investigational Site Memphis Tennessee 38115
Novo Nordisk Investigational Site Arlington Texas 76014
Novo Nordisk Investigational Site Dallas Texas 75208
Novo Nordisk Investigational Site Dallas Texas 75230
Novo Nordisk Investigational Site Dallas Texas 75231
Novo Nordisk Investigational Site Dallas Texas 75246
Novo Nordisk Investigational Site Dallas Texas 75390-8858
Novo Nordisk Investigational Site Houston Texas 77030
Novo Nordisk Investigational Site Lewisville Texas 75067
Novo Nordisk Investigational Site Midland Texas 79707
Novo Nordisk Investigational Site Plano Texas 75074
Novo Nordisk Investigational Site Plano Texas 75093
Novo Nordisk Investigational Site San Antonio Texas 78229
Novo Nordisk Investigational Site Ogden Utah 84403
Novo Nordisk Investigational Site Newport News Virginia 23606
Novo Nordisk Investigational Site Richmond Virginia 23249
Novo Nordisk Investigational Site Warrenton Virginia 20186
Novo Nordisk Investigational Site Bellevue Washington 98004
Novo Nordisk Investigational Site Milwaukee Wisconsin 53209

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00097877, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 10, 2017 · Synced May 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00097877 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →